Stay updated on Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.

Latest updates to the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page
- Check4 days agoChange DetectedThe Record History shows a new revision labeled v3.4.3, replacing the previous v3.4.2. This indicates a minor site update.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new version entry was added to the record history on 2023-01-10. It documents updates to recruitment status, study status, and related study details (design, contacts/locations).SummaryDifference0.1%

- Check33 days agoChange DetectedThe record history now shows a new revision entry (v3.4.2) and the previous revision (v3.4.1) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedNew revision version 3.4.1 was added to the record history, replacing the previous 3.4.0 revision. This is a metadata update reflecting version control rather than changes to study information.SummaryDifference0.1%

- Check47 days agoChange DetectedThe Record History page adds a Show glossary option and green/red highlights for additions and deletions. It also updates to Revision v3.4.0 and adjusts the No FEAR Act Data label.SummaryDifference1%

- Check62 days agoChange DetectedRevision history shows a new site release (v3.3.4) added and the previous release (v3.3.3) removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.